| Each issue of Med Ad News delivers broad coverage
and penetrating analysis of the issues, events, trends, and strategies
shaping the pharmaceutical industry. Through a combination of industry
expertise and extensive research, our editors provide news content and
analysis that is original, exclusive, and proactive. We examine historical
industry trends and current news to provide objective insight into industry
business and the marketing of medicines.
Med Ad News is read by senior management, marketing
and sales professionals, product and account managers, and R&D professionals
representing pharmaceutical, biotechnology, and medical device manufacturers,
health-care and general business companies, and marketing support agencies,
among others.
Because it offers reliable, compelling, and need-to-know
information, Med Ad News has attracted a high-quality, loyal readership.
A recent independent survey among subscribers attests to how highly they
value Med Ad News' content.
--Nearly 50% have been subscribers for at least five years
--Seventy-four percent read three out of every four issues
--Subscribers spend an average of 42 minutes reading
each issue
--On average, subscribers save their issues for almost
eight months
--When asked which one industry publication (among four
surveyed) they would choose to receive if they could receive only one,
they chose Med Ad News by an overwhelming majority.
|
